Search research articles
Contact Us
Filters
Showing results (121-130 of 165) with videos related to
Page
of 17
Sort By:
The New England Journal of Medicine
|
December 3, 2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy
Paul E Sax, Camlin Tierney, Ann C Collier, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
Journal of Virology
|
April 29, 2011
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors
J Gerardo García-Lerma, Wutyi Aung, Mian-er Cong, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants
Patricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
Antimicrobial Agents and Chemotherapy
|
September 23, 2024
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084
Mark A Marzinke, Kelong Han, Brett Hanscom, et al.
Pharmaceutics
|
October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
Fernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
The Journal of Infectious Diseases
|
November 8, 2025
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
Brett Hanscom, Mark A Marzinke, Xinnong Li, et al.
Microbiology Spectrum
|
July 9, 2024
Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis
Jessica M Fogel, Estelle Piwowar-Manning, Amber Moser, et al.
JMIR Research Protocols
|
February 4, 2020
Testing the Effectiveness and Cost-Effectiveness of a Combination HIV Prevention Intervention Among Young Cisgender Men Who Have Sex With Men and Transgender Women Who Sell or Exchange Sex in Thailand: Protocol for the Combination Prevention Effectiveness Study
Andrea L Wirtz, Brian Wilson Weir, Sandra Hsu Hnin Mon, et al.
AIDS (London, England)
|
November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
Kristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 165) with videos related to
Sort By:
Page
of 17
The New England Journal of Medicine
|
December 3, 2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy
Paul E Sax, Camlin Tierney, Ann C Collier, et al.
Leukemia & Lymphoma
|
September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)
R M Lowenthal, K F Bradstock, J P Matthews, et al.
Journal of Virology
|
April 29, 2011
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors
J Gerardo García-Lerma, Wutyi Aung, Mian-er Cong, et al.
Antimicrobial Agents and Chemotherapy
|
September 8, 2011
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants
Patricia M Flynn, Mark Mirochnick, David E Shapiro, et al.
Antimicrobial Agents and Chemotherapy
|
September 23, 2024
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084
Mark A Marzinke, Kelong Han, Brett Hanscom, et al.
Pharmaceutics
|
October 21, 2020
Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant
Fernanda P Pons-Faudoa, Nicola Di Trani, Antons Sizovs, et al.
The Journal of Infectious Diseases
|
November 8, 2025
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
Brett Hanscom, Mark A Marzinke, Xinnong Li, et al.
Microbiology Spectrum
|
July 9, 2024
Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis
Jessica M Fogel, Estelle Piwowar-Manning, Amber Moser, et al.
JMIR Research Protocols
|
February 4, 2020
Testing the Effectiveness and Cost-Effectiveness of a Combination HIV Prevention Intervention Among Young Cisgender Men Who Have Sex With Men and Transgender Women Who Sell or Exchange Sex in Thailand: Protocol for the Combination Prevention Effectiveness Study
Andrea L Wirtz, Brian Wilson Weir, Sandra Hsu Hnin Mon, et al.
AIDS (London, England)
|
November 30, 2020
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV
Kristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, et al.
Page
of 17